• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, September 26, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Retromer Complex Identified as a New Key Regulator of Melanoma Metastasis

Bioengineer by Bioengineer
September 6, 2025
in Cancer
Reading Time: 3 mins read
0
Retromer Complex Identified as a New Key Regulator of Melanoma Metastasis
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In the relentless battle against cancer metastasis, the intricate molecular mechanisms that govern cellular invasiveness remain at the forefront of scientific inquiry. A recent study published in Science China Life Sciences unravels a dual regulatory role of the VPS35/Retromer complex in controlling MT1-MMP, a membrane-bound matrix metalloproteinase pivotal for tumor invasion and metastatic progression. This groundbreaking research sheds light on how VPS35 orchestrates both the stability and transcriptional regulation of MT1-MMP, revealing novel therapeutic angles to intercept cancer metastasis.

Metastasis, the process by which cancer cells disseminate from primary tumors to distant organs, is critically dependent on the cell’s ability to degrade and remodel the extracellular matrix (ECM). MT1-MMP (Membrane-type 1 matrix metalloproteinase) is a key player in this remodeling, enabling cancer cells to breach basement membranes and invade adjacent tissues. Yet, the molecular entities governing the balance between MT1-MMP degradation and recycling within cancer cells have remained incompletely understood until now.

Central to this study is the VPS35/Retromer complex, a pivotal intracellular trafficking hub known for its role in sorting and recycling transmembrane proteins from endosomes back to the plasma membrane. The researchers demonstrate that VPS35 directly binds MT1-MMP, effectively shielding the enzyme from lysosomal degradation. This protective interaction ensures the maintenance of MT1-MMP protein stability on the cancer cell surface, thereby sustaining the cells’ invasive capabilities.

When VPS35 expression is experimentally depleted in melanoma models, a pronounced reduction in MT1-MMP protein levels is observed both on the plasma membrane and intracellular compartments. This decrease is mechanistically linked to enhanced lysosomal degradation, underscoring the importance of VPS35-mediated recycling pathways in preserving functional MT1-MMP pools necessary for matrix degradation.

Further validation of VPS35’s role in metastasis is evident from in vivo lung metastasis models, where VPS35-deficient melanoma cells exhibit dramatically diminished metastatic spread. Intriguingly, reconstitution of MT1-MMP levels in these VPS35-depleted cells successfully rescues their metastatic potential, affirming that the pro-metastatic function of VPS35 is critically dependent on maintaining adequate MT1-MMP protein presence.

Crucially, VPS35 knockdown leads to impaired STAT3 phosphorylation and activation upon IL-6 stimulation, resulting in a marked reduction in MT1-MMP mRNA levels. This discovery is significant because it positions VPS35 at the nexus of both protein recycling and gene expression regulation, thus exerting a “double-hit” effect on MT1-MMP availability within cancer cells.

Complementing these molecular findings, clinical data from melanoma patient samples reveal a robust positive correlation between VPS35 and MT1-MMP expression levels. Patients exhibiting elevated VPS35 and MT1-MMP concomitantly face poorer prognoses, suggesting that this axis could serve as a valuable biomarker for disease progression and therapeutic targeting.

The implications of this research are profound. By simultaneously disrupting VPS35’s ability to stabilize MT1-MMP protein and potentiate its transcription, novel therapies could decisively cut off the enzymatic machinery that cancer cells rely on to metastasize. This bifurcated regulatory mechanism presents an attractive therapeutic target, potentially yielding treatments that are both effective and selective.

From a technical perspective, the study employed an array of experimental techniques including gene silencing, in vitro invasion assays, lysosomal inhibition studies, and in vivo metastasis models, combined with transcriptional activity assays and patient data analyses. This multifaceted approach solidifies the mechanistic insights and translational relevance of the findings.

Furthermore, the complex interplay between VPS35 and STAT3 highlights an emerging paradigm wherein intracellular trafficking proteins also modulate key oncogenic signaling cascades. This dual role challenges the traditional view of endosomal sorting complexes as mere logistical entities, broadening their functional repertoire in cancer biology.

Moving forward, therapeutic strategies could exploit small molecules or biologics designed to inhibit VPS35 function or its interaction with MT1-MMP and STAT3. Such interventions might impair cancer cell invasiveness by engineering a sustained reduction in MT1-MMP availability, effectively halting metastatic cascades at multiple regulatory nodes.

Subject of Research: Mechanistic elucidation of VPS35/Retromer complex regulation of MT1-MMP in cancer metastasis.

Article Title: (Information not explicitly provided)

News Publication Date: (Information not explicitly provided)

Web References: http://dx.doi.org/10.1007/s11427-024-2884-2

References: (Detailed references from the original article are not provided)

Image Credits: (Not specified)

Keywords: VPS35, Retromer complex, MT1-MMP, cancer metastasis, STAT3 signaling, protein recycling, lysosomal degradation, transcriptional regulation, melanoma, IL-6, extracellular matrix, tumor invasion

Tags: cancer cell invasiveness factorsdual regulatory role of VPS35extracellular matrix remodeling in tumorsintracellular trafficking and cancerlysosomal degradation and cancer cellsmembrane-type 1 matrix metalloproteinase insightsmolecular mechanisms of tumor invasionMT1-MMP regulation mechanismsnovel approaches to intercept metastasisRetromer complex in cancer researchtherapeutic targets for cancer metastasisVPS35 role in melanoma metastasis

Share12Tweet8Share2ShareShareShare2

Related Posts

Study Predicts Kidney Cancer Cases Will Double by 2050

September 26, 2025

Theranostics: Precision Oncology’s Nuclear Medicine Revolution

September 26, 2025

ASTRO 2025: SBRT Matches Surgery in Effectiveness for Early-Stage Lung Cancer After 10 Years

September 26, 2025

University of Cincinnati Cancer Center Researcher Innovates Pancreatic Cancer Therapy Targeting Newly Discovered Protein

September 26, 2025

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    80 shares
    Share 32 Tweet 20
  • Physicists Develop Visible Time Crystal for the First Time

    72 shares
    Share 29 Tweet 18
  • Scientists Discover and Synthesize Active Compound in Magic Mushrooms Again

    55 shares
    Share 22 Tweet 14
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cerebral Autoregulation Patterns in Neonatal Heart Surgery

Coral Grouper Genome Reveals Eupercaria Evolutionary Insights

Parental Antibiotic Self-Medication Awareness in Bandung

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.